<p>Disclosed herein are novel pharmaceutical cocrystals of temozolomide using co-crystal coformers selected from aliphatic and aromatic carboxylic acids in fixed stoichiometric ratio. The novel Temozolomide-carboxylic acid cocrystals exhibit improved hydrolytic stability and good aqueous dissolution rate compared to the pure drug.</p>
